Systematic review: general correlation of STEMI in adult patients after COVID-19
Revisão sistemática: correlação geral de IAMCSST em pacientes adultos após COVID-19
Palavras-chave:
Acute Myocardial Infarction, Covid-19, PandemicResumo
Introduction: SARS-CoV-2 can damage the myocardium by viral invasion directly or indirectly through inflammation, endothelial activation and microvascular thrombosis, increasing the risk of cardiovascular complications, including Myocarditis, Arrhythmias and Acute Myocardial Infarction (AMI) , with emphasis on AMI with ST Supra (STEMI). Objective: To analyze the main aspects in the STEMI scenario after covid-19, focusing on elucidating whether there is a change in morbidity and mortality and how to manage it in the context of the general practitioner. Methods: Integrative literature review carried out in the bases of PUBMED, Virtual Health Library (BVS), SciELO and LILACS, with the following descriptors “Acute myocardial infarction” and “Covid-19” and the Boolean “AND”. The filters used were the “last 3 years” and “free text”. Non-relevant articles were excluded, 23 articles were included in this review. Results: Pulmonary implications, especially COVID-19, result in a worse prognosis in patients with STEMI, and early detection and implementation of optimal therapeutic strategies for the effective treatment of the condition are of paramount importance.
Downloads
Referências
AL-ALY, Z.; XIE, Y.; BOWE, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature, v. 594, n. 7862, p. 259–264, 10 jun. 2021.
AYOUBKHANI, D. et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ, p. n693, 31 mar. 2021.
AZEVEDO, R. B. et al. Covid-19 and the cardiovascular system: a comprehensive review. Journal of Human Hypertension, v. 35, n. 1, p. 4–11, 27 jan. 2021.
BHATT, D. L.; LOPES, R. D.; HARRINGTON, R. A. Diagnosis and Treatment of Acute Coronary Syndromes. JAMA, v. 327, n. 7, p. 662, 15 fev. 2022.
CESAR, L. et al. Guideline For Stable Coronary Artery Disease. Arquivos Brasileiros de Cardiologia, v. 103, n. 2, 2014.
DAUGHERTY, S. E. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ, p. n1098, 19 maio 2021.
DEL PRETE, A. et al. COVID-19, Acute Myocardial Injury, and Infarction. Cardiac Electrophysiology Clinics, v. 14, n. 1, p. 29–39, mar. 2022.
DIXIT, N. M. et al. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? American Heart Journal Plus: Cardiology Research and Practice, v. 5, p. 100025, maio 2021.
FERNANDES, Q. et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Annals of Medicine, v. 54, n. 1, p. 524–540, 31 dez. 2022.
GHASEMZADEH, N. et al. A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19. Cardiology Clinics, v. 40, n. 3, p. 321–328, ago. 2022.
GIUSTINO, G. et al. Characterization of Myocardial Injury in Patients With COVID-19. Journal of the American College of Cardiology, v. 76, n. 18, p. 2043–2055, nov. 2020.
ITO, G. N. W. et al. COVID‐19: pathophysiology and ultrasound imaging: A multiorgan review. Journal of Clinical Ultrasound, v. 50, n. 3, p. 326–338, 26 mar. 2022.
JIN, Y.-H. et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research, v. 7, n. 1, p. 4, 6 dez. 2020.
KHETPAL, V. et al. Long-term Cardiovascular Manifestations and Complications of COVID-19: Spectrum and Approach to Diagnosis and Management. Rhode Island medical journal (2013), v. 105, n. 7, p. 16–22, 1 set. 2022.
LONG, B. et al. Cardiovascular complications in COVID-19. The American Journal of Emergency Medicine, v. 38, n. 7, p. 1504–1507, jul. 2020.
MINISTERIO DA SAUDE. NOTA TÉCNICA No 14/2022-CGGRIPE/DEIDT/SVS/MS. Brasília : [s.n.].
MODIN, D. et al. Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction. Circulation, v. 142, n. 21, p. 2080–2082, 24 nov. 2020.
PELLICORI, P. et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Systematic Reviews, v. 2022, n. 4, 11 mar. 2021.
PERROTTA, F. et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clinical and Experimental Research, v. 32, n. 8, p. 1599–1608, 16 ago. 2020.
PIEGAS, L. et al. V DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA SOBRE TRATAMENTO DO INFARTO AGUDO DO MIOCÁRDIO COM SUPRADESNÍVEL DO SEGMENTO ST. Arquivos Brasileiros de Cardiologia, v. 105, n. 2, 2015.
RAMAN, B. et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. European Heart Journal, v. 43, n. 11, p. 1157–1172, 14 mar. 2022.
RICHARDSON, S. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA, v. 323, n. 20, p. 2052, 26 maio 2020.
SAAD, M. et al. Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA, v. 326, n. 19, p. 1940, 16 nov. 2021.
TAN, Z. C. et al. Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations]. Zhonghua xin xue guan bing za zhi, v. 48, n. 0, p. E005, 2 mar. 2020.
WONG, S. W. et al. ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. Annals of the Academy of Medicine, Singapore, v. 50, n. 5, p. 425–430, 31 maio 2021.
WORLD HEALTH ORGANIZATION. WHO Coronavirus (COVID-19) Dashboard.
WU, Z.; MCGOOGAN, J. M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, v. 323, n. 13, p. 1239, 7 abr. 2020.
